1. Please can you send me a link to your transplant guidelines? I would like to know what tacrolimus is used and why?
Please see attached. SOP 008 V9 I1 Management of GvHD in allo recipients AK
This document is intended to develop a standard operating procedure for the management of graft versus host disease occurring in recipients of allogeneic blood progenitor cell transplants at Birmingham Heartlands Hospital.
We use tacrolimus as second line immunosuppression if the patient experiences significant side effects with ciclosporin (severe allergic reactions, hypertension, renal or hepatic impairment, fluid retention, evidence of ciclosporin related TTP).
2. Also could you tell me who is on the Drugs and therapeutics committee please?
Tania Carruthers – Clinical Director of Pharmacy
Carol Evans – Interfacing Prescribing Manager
Yogita Chikermane – Consultant Anaesthetics
Gurdeep Chopra – Principal Pharmacist – Clinical Effectiveness & Medication Safety
Katy Davies – Pharmacist – Medicines Information
Siljia Eveson – Midwife
Kavita Gopee – Nurse
Scott Hackett – Consultant Paediatrics/Neonates
Natasha Jacques – Principal Pharmacist – Specialised Medicine & Community Services
Karen Ennis – Assistant Head of Medicines Management CCG
Nilima Rahman-Lais – Deputy Head of Medicines Management CCG
Charalampos Kartsios – Consultant Haematology
Caroline Maynard – Faculty Nurse Educator
Shahzad Razaq – Principal Pharmacist – Medicine and Anti-Infectives
Ellen Shirley – Principal Pharmacist – Cancer Services
Vijayan Suresh – Consultant Renal
Su Dorrian – Consultant Emergency Department
Rachel Ferreday – General Manager Division 1
Tim Priest – Consultant Anaesthetist